Market cap
$85 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -4.81 | 32.11 | 16.76 | 4.52 | -26.31 |
| Net Profit | -5.50 | 31.58 | 16.57 | 4.48 | -25.48 |
| EPS | -5.49 | 63.75 | 38.13 | 19.37 | 10.70 |
| Book Value | -- | -- | -32.01 | -40.97 | -23.74 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | -70.86 | -67.55 | -65.65 |
| Return on Capital
| -- | -- | -- | -61.83 | -59.31 |
| Return on Assets
| -- | -- | -57.17 | -56.62 | -54.79 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.09 | 0.09 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
-61.83
|
-59.31
|
1,097.71
|
36.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-70.86
Lower than Peers by 30.46
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
-70.86
|
-67.55
|
-65.65
|
419.96
|
32.98
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-57.17
Lower than Peers by 26.20
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
-57.17
|
-56.62
|
-54.79
|
-53.03
|
-20.02
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
-290.32
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
-268.22
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
-1.00
|
1.57
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
16.76
Higher than Peers by 17.56
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
16.76
|
0.30
|
17.89
|
-104.61
|
-18.10
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
16.57
Higher than Peers by 23.87
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
16.57
|
0.27
|
17.90
|
-104.41
|
-8.11
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
38.13
Higher than Peers by 23.48
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
38.13
|
0.21
|
0.60
|
-0.98
|
-0.01
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-52.28
Lower than Peers by 42.10
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
-52.28
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
0.09
|
0.09
|
0.12
|
-0.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
0.02
|
0.02
|
0.02
|
0.02
|
-0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.71
Higher than Peers by 0.90
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
6.71
|
7.47
|
9.29
|
8.41
|
13.25
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
6.71
Higher than Peers by 1.01
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
6.71
|
--
|
--
|
--
|
13.12
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-1,219.14
Lower than Peers by 1,217.05
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
-1,219.14
|
-3,243.53
|
-29,279.50
|
-5,705.32
|
-906.89
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
1.74
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
0.07
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
4.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
153.75
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
273.87
|
210.49
|
210.51
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
-0.50
|
-0.05
|
-0.04
|
-1.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.70
Lower than Peers by 4.48
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
0.70
|
0.36
|
0.03
|
0.03
|
-0.44
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-1.21
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
-1.21
|
0.78
|
1.39
|
0.98
|
1.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
85
Lower than Peers by 61
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Jun-23
|
|---|---|---|---|---|---|
|
Adicet Bio (ACET)
|
85
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|